Featured · Regulation & Policy
Psychedelics in Mental Health: From Clinical Trials to State Lines
In this episode, Jennifer Cutler, a partner at DCI Group, discusses the evolving landscape of psychedelic treatments for mental health issues. She highlights the FDA's role in approving various psychedelic products aimed at conditions like PTSD and depression, while emphasizing the challenges states face in implementing these therapies after federal approval. Cutler notes the bipartisan support for mental health initiatives, particularly for veterans, and identifies states like Colorado and Illinois as leaders in legislative progress regarding psychedelic-assisted therapy.
2026-08-27 · with Jennifer Cutler
